STERIMED Infection Control
Thibaut HYVERNAT has a diverse work experience spanning several industries and positions. Thibaut is currently the President & CEO of STERIMED Infection Control since October 2016. Thibaut also holds the position of President of the Handicap Commission at METI - Mouvement des Entreprises de Taille Intermédiaire since September 2021. Additionally, they serve as the Chairman of the Sterile Barrier Association since October 2021 and has been a Director since March 2013. Thibaut also has experience as an Independent Board Member at Maisons & Domaines Henriot from June 2018 to November 2022. Prior to these roles, they were the Managing Director at Arjowiggins Healthcare from January 2010 to October 2016, where they led the world leader in sterilization packaging substrates. Thibaut has further experience as a Group Chief Financial Officer at Arjowiggins Group in 2009, and as a Group Strategy Director at SEQUANA in the same year. Thibaut started their career as an Investment Manager at Worms & Cie from 2001 to 2005 before joining Sequana Capital as an Investments and Financing Director from 2005 to 2009. Thibaut has a strong background in finance and strategic planning across various organizations.
Thibaut HYVERNAT attended the Cycle des Hautes Études pour le Développement Économique - CHEDE from 2015 to 2016. Thibaut obtained the degree of CHEDE (Cycle des Hautes Etudes pour le Développement Economique - Ministères de Bercy) and was a former auditor in the promotion Marie Curie (2016). Prior to that, they attended the ESSEC Business School from 2000 to 2002 for the Programme grande école. Thibaut also studied at Sciences Po from 1998 to 2000, specializing in the Section Service Public.
This person is not in any offices
STERIMED Infection Control
1 followers
We are a French group and one of the world leaders in the manufacture of sterilization packaging for medical device manufacturers, patient care facilities and the pharmaceutical industry. We are experts in both the manufacture of specialty substrates (paper, polybond®, film, etc.) and the production and supply of ready-to-use sterilization packaging and consumables. As such, we guarantee absolute quality control throughout the supply chain for the utmost safety of patients and caregivers. Concerned with a permanent dynamic of innovation, our R&D teams work on customized developments for our customers and are constantly developing new materials, processes and designs into which we integrate as many renewable resources as possible, in the interests of performance, product use and our customers. OUR MISSION Our primary mission is the prevention of and the fight against healthchare-associated infections. Daily our teams, alongside our customers and partners, strive to: • Ensure the sterilization of medical devices and maintain their sterile state until they are used, • Guarantee the protection of patients and healthcare personnel, • Offer high-quality products that comply with the safety and performance requirements of the healthcare industry and in particular medical devices, • Innovate for greater technicality and competitiveness, with a constant concern for environmental protection, • Respect humankind, the environment and our communities in a spirit of cooperation. CSR at STERIMED At STERIMED, we believe that it is our duty, beyond economic performance, to also respond and commit to environmental and societal performance. Consult our CSR report https://www.sterimed.fr/en/about-us/sustainability KEY NUMBERS Sites in France, US, Mexico, China, Spain, Germany, Czech Republic and UK 12 production sites, 10 distribution centers Present on 3 continents 1,350 employees 1 medical device in 4 across the world is packagedwith our products